What is SHTDF's gross margin?

Sinopharm (SHTDF) has a gross margin of 7% and a net margin of 1%.

What is SHTDF's P/E ratio?

SHTDF's P/E ratio is 5.6 with ROE of 17%.

Where can I see SHTDF's full financials?

See Sinopharm (SHTDF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Sinopharm (SHTDF) Financials — Revenue, Earnings, Cash Flow

Also trades as: 1099.HK (HKSE) · $vol 11M · SHTDY (OTC) · $vol 1M

$1.87

+0.04 (+2.41%)

Weekly Expected Move ±12.4%

$1 $2 $2 $2 $2

OTC · Healthcare · Medical - Distribution · Tech Score Strong Sell · Power 40 · $5.8B mcap · 1.34B float · 0.0014% daily turnover · Short 93% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$1,139B

Revenue

+9.8% YoY

$14B

Net Income

-21.6% YoY

$35B

Free Cash Flow

+42.2% YoY

6.7%

Gross Margin

2.9%

Op. Margin

1.2%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE17.2%

ROA3.3%

ROIC15.0%

Valuation

P/E5.6

P/B0.5

EV/EBITDA0.0

Leverage

Debt/Equity1.34

Current Ratio1.40

Interest Cov.9.1x

Quality Scores

Piotroski F6/9

Altman Z—

Beneish M-2.72